Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
PRFX
PRFX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest PRFX ETF News Today | Earnings, Events & Price Alerts
PRFX News
PRF Technologies Partners with EDF for Solar Analytics Agreement
Feb 18 2026
Newsfilter
PRF Technologies Signs SaaS Agreement with Shikun & Binui Energy for Solar Analytics
Feb 11 2026
Newsfilter
PRF TECHNOLOGIES LTD - INSTALLATION OF DEEPSOLAR AT 71 MW FACILITY IN ROMANIA
Feb 11 2026
moomoo
Rapt Therapeutics Acquired by GSK for $58 per Share, Valuing at $2.2 Billion
Jan 20 2026
Benzinga
PainReform Ltd. Changes Name to PRF Technologies, Stock Rises 48%
Jan 16 2026
Benzinga
PainReform Ltd. (PRFX) Announces Name Change, Shares Surge 27.4%
Jan 16 2026
Benzinga
PRF Technologies Ltd. Rebrands, Expands into Diverse Markets
Jan 15 2026
Globenewswire
BladeRanger Joins Abu Dhabi Sustainability Week to Drive $600 Billion Energy Investment
Dec 30 2025
Newsfilter
BladeRanger Joins Abu Dhabi Sustainability Week to Drive $600 Billion Energy Investment
Dec 30 2025
PRnewswire
PainReform Initiates OcuRing-K Development Plan Targeting 4.5 Million Cataract Surgeries Annually
Dec 02 2025
Newsfilter
PainReform Initiates OcuRing-K Development Plan Targeting Ophthalmic Market
Dec 02 2025
Globenewswire
PainReform's DeepSolar Progresses in Developing AI-Powered Automated Reporting System for Solar Asset Evaluation
Nov 12 2025
Newsfilter
PainReform's DeepSolar, Advancing "DeepSolar Predict" through the NVIDIA Connect Program, Highlighted in The Market Link's "Watchlist Interview" and Reports Progress on Pilot Projects
Nov 05 2025
Newsfilter
Rocket Pharmaceuticals Shares Surge Over 15%; Check Out 20 Stocks Making Moves in Premarket Trading
Aug 20 2025
Benzinga
US Stocks Show Varied Performance; Home Depot Sees Share Increase Following Q2 Earnings Report
Aug 19 2025
Benzinga
Key Stocks to Monitor: IOVA Rises Following Regulatory Approval, FDA Expedites Aldeyra's Medication
Aug 19 2025
NASDAQ.COM
Show More News
